Knowledge Home Human Health Knowledge All Opinion Papers Popular science Interviews Filter Therapeutic areasCOVID-19Digestive health Apply Home Human Health Knowledge Preclinical evaluation of PHH-1V candidate against SARS-CoV-2 in non-human primates Home Human Health Knowledge RBDCOV Talks HIPRA’s participation: In 5 minutes, what is a recombinant protein vaccine? Home Human Health Knowledge RBDCOV: The project’s origins and future endeavours Home Human Health Knowledge Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19 Home Human Health Knowledge Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 Home Human Health Knowledge Humoral immune response against XBB.1.5 and BQ.1.1 SARS-CoV-2 variants of a fourth dose of PHH-1V vaccine in adult subjects Home Human Health Knowledge Reactogenicity of third and fourth booster doses of HIPRA PHH-1V, a bivalent recombinant protein vaccine against SARS-CoV-2 Home Human Health Knowledge Humoral immune response against SARS-CoV-2 variants of PHH-1V booster vaccine in subjects previously vaccinated with a mRNA vaccine Home Human Health Knowledge One-year humoral response of PHH-1V booster vaccine in subjects previously vaccinated against COVID-19 with a mRNA vaccine Load more
